IMMUNE PHARMACEUTICALS INC Note Agreements
13 Contracts & Agreements
- Form of Investor Note (Filed With SEC on October 10, 2018)
- Convertible Promissory Note, dated September 12, 2018, by and between Immune Pharmaceuticals, Inc. and Power Up Lending Group Ltd (Filed With SEC on September 18, 2018)
- SENIORSECURED CONVERTIBLEPROMISSORY NOTE DUEJuly 7, 2018 (Filed With SEC on July 10, 2017)
- 6% CONVERTIBLE NOTE (Filed With SEC on April 19, 2017)
- PROMISSORY NOTE (Filed With SEC on July 19, 2016)
- EX-10.22: 8% SENIOR NOTE (Filed With SEC on November 1, 2005)
- EX-10.21: 8% SENIOR NOTE (Filed With SEC on November 1, 2005)
- EX-10.20: AMENDED AND RESTATED 8% SENIOR NOTE (Filed With SEC on November 1, 2005)
- EX-10.19: AMENDED AND RESTATED 8% SENIOR NOTE (Filed With SEC on November 1, 2005)
- EX-10.18: AMENDED AND RESTATED NOTE PURCHASE AGREEMENT (Filed With SEC on November 1, 2005)
- EX-4.3: FORM OF FOURTH AMENDED AND RESTATED CONVERTIBLE TERM NOTE (Filed With SEC on November 1, 2005)
- EX-10.20: FORM OF NOTE ISSUED PURSUANT TO THE NOTE PURCHASE AGREEMENT (Filed With SEC on April 18, 2005)
- EX-10.18: NOTE PURCHASE AGREEMENT (Filed With SEC on March 30, 2005)
